LUGPA Policy Update: Insurers Advance Prior Authorization Standardization Efforts

May 2026

At-a-Glance Essentials

What’s Changing:
Major insurers, including UnitedHealthcare, Aetna, and Cigna, are advancing an industry-wide effort to standardize prior authorization (PA) processes through initiatives led by America's Health Insurance Plans and the Blue Cross Blue Shield Association.

Why It Matters:
Prior authorization remains a major administrative burden for urology practices. While insurers report efficiency gains, it remains unclear whether reforms will meaningfully reduce delays and documentation requirements.

Overview

National insurers are moving forward with voluntary efforts to streamline prior authorization across commercial insurance, Medicare Advantage, and Medicaid managed care. The initiative focuses on reducing PA requirements, expanding electronic prior authorization (ePA), and improving transparency.

Early insurer-reported results include:

• An 11% reduction in PA requirements overall, including a 15% reduction in Medicare Advantage
• Expanded use of electronic and real-time approvals
• Standardized documentation and submission formats across plans

At the plan level:

• UnitedHealthcare reports standardization for more than 50% of PA volume
• Aetna reports 88% standardization and rapid approval turnaround times
• Cigna reports reduced PA volume and expanded standardization efforts

Expanding Industry Collaboration

Momentum behind prior authorization reform increased following remarks by Mehmet Oz at the Axios Future of Health Summit, where he announced a coalition of 29 healthcare organizations working to modernize PA processes.

The coalition includes insurers, hospitals, providers, and health IT companies, including Cleveland Clinic, Bon Secours Mercy Health, and AtlantiCare. CMS officials stated that the goal is to support more automated, near-real-time prior authorization decisions through improved electronic data exchange, with some “touchless” determinations potentially available by January 2027.

The announcement reflects growing federal pressure to modernize utilization management practices as concerns continue regarding delays in care, physician burnout, and administrative burden—particularly within Medicare Advantage.

CMS is also pursuing broader technology-driven oversight initiatives, including limited AI-supported pre-treatment review systems, which raise ongoing questions about transparency, clinical oversight, and physician autonomy.

Implications for Urology Practices

Potential benefits include faster approvals for imaging, cancer therapies, and procedures, as well as reduced variation across payers. However, practices may still face a significant administrative burden unless insurers continue to reduce the scope of PA requirements.

Expanded ePA adoption may also require additional investment in workflow integration and staff training.

LUGPA Perspective

LUGPA continues to advocate for meaningful prior authorization reform, including:

• Reducing the number of services subject to PA
• Improving transparency and clinical validity
• Expanding real-time approvals
• Aligning payer policies with evidence-based care

While insurer-led reforms represent incremental progress, policymakers and regulators continue evaluating additional federal and state oversight of prior authorization practices, particularly in Medicare Advantage.

Bottom Line

The insurer-led initiative may improve consistency and efficiency, but the true impact for urology practices will depend on whether reforms produce lasting reductions in administrative burden and improve timely patient access to care.